Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Xperi Inc. (XPER) Stock Forecast 2025 - AI Price Prediction & Analysis

Xperi Inc. (XPER) AI Stock Price Forecast & Investment Analysis

Xperi Inc. Stock Price Chart and Technical Analysis

Loading Xperi Inc. interactive price chart and technical analysis...

Xperi Inc. (XPER) - Comprehensive Stock Analysis & Investment Research

Deep dive into Xperi Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Xperi Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Xperi Inc.: Xperi Inc. operates in the Technology sector, making it an emerging small-cap investment.

Xperi Inc. (Stock Symbol: XPER) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 1800 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Xperi Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Xperi Inc.: With $453M in annual revenue and -16.7% net margin, the company demonstrates developing profitability.

Annual Revenue: $453 million generating a -16.7% net profit margin .

Market Capitalization: $279 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -2.6% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Xperi Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Xperi Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Xperi Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Xperi Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Xperi Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

Xperi Inc. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $238 million annually, complemented by impressive 152.6% year-over-year cash flow growth.

The company maintains a healthy 100.0% gross margin, indicating strong pricing power and operational efficiency.

Xperi Inc. (XPER) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Xperi Inc. stock analysis.

Loading Xperi Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Xperi Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Xperi Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Xperi Inc.: With a P/E ratio of 40.03, the market highly values future growth prospects.

P/E Ratio 40.03x
P/B Ratio 0.65x
Market Cap $279M
EPS $-0.07
Book Value/Share $9.26
Revenue/Share $9.81
FCF/Share $2.69
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Xperi Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Xperi Inc.: An ROE of -2.6% indicates room for improvement in shareholder value creation.

ROE -2.6%
ROA -1.4%
ROIC -0.6%
Gross Margin 100.0%
Operating Margin -20.2%
Net Margin -16.7%
EBT Margin 1.6%
Tax Rate 372.9%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Xperi Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Xperi Inc.: A current ratio of 2.71 indicates strong liquidity.

Current Ratio 2.71x
Quick Ratio 2.49x
D/E Ratio 0.57x
Financial Leverage 1.82x
Interest Coverage 1.4x
Working Capital $322M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Xperi Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Xperi Inc.: Free cash flow of $238M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $254M
Free Cash Flow $238M
Capital Spending $-17M
OCF Growth YoY 152.6%
FCF Growth YoY 136.8%
FCF/Sales 26.0%
CapEx/Sales 1.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Xperi Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Xperi Inc.: An asset turnover of 0.36x suggests room for improvement in asset utilization.

Asset Turnover 0.36x
Receivables Turnover 8.2x
Inventory Turnover 16.4x
Fixed Assets Turnover 7.0x
Days Sales Outstanding 44 days
Days Inventory 22 days
Payables Period 52 days
Cash Conversion Cycle 14 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Xperi Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Xperi Inc.: With annual revenue of $453M, Xperi Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $453M
R&D Expense $205M
SG&A Expense $29M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 21%
Cash & Short-term Investments 11%
Total Liabilities 45%
Short-term Debt 1%
Accounts Receivable 9%
Inventory 0%
Dividend & Shareholder Information
Dividends Per Share $0.05
Payout Ratio -1.0%
Shares Outstanding 46M
Growth Metrics (YoY)
EPS Growth -20.6%

Latest Xperi Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Xperi Inc. (XPER) stock price and investment outlook.

, source: Seeking Alpha

Good day, everyone. Thank you for standing by. Welcome to the Xperi Fourth Quarter and Full Year 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Mike ...

, source: Business Wire

SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary ...

, source: Business Wire

SAN JOSE, Calif.--(BUSINESS WIRE)--Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary ...

, source: Insider Monkey

Xperi Inc. reports earnings inline with expectations. Reported EPS is $0.11 EPS, expectations were $0.11. Operator: Good day, everyone. Thank you for standing by. Welcome to the Xperi Second Quarter ...

, source: Morningstar

Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary experiences, today announced that ...

, source: Morningstar

View source version on businesswire.com: https://www.businesswire.com/news/home/20251105094103/en/ The articles, information, and content displayed on this webpage ...

Xperi Inc. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Xperi Inc. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $4741M 18.2x 3.2x
ADBE Unlock Forecast - 30 Days FREE Trial $145429M 20.9x 12.4x
AEYE Unlock Forecast - 30 Days FREE Trial $163M -61.5x 28.8x
AI Unlock Forecast - 30 Days FREE Trial $2041M -16.8x 2.6x
AIFF Unlock Forecast - 30 Days FREE Trial $23M -4.2x 2.4x
AISP Unlock Forecast - 30 Days FREE Trial $118M x -7.3x
ALKT Unlock Forecast - 30 Days FREE Trial $2262M -75.9x 6.5x
ALRM Unlock Forecast - 30 Days FREE Trial $2593M 20.4x 3.1x
ALSAF Unlock Forecast - 30 Days FREE Trial $40M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
AMPL Unlock Forecast - 30 Days FREE Trial $1466M -16.9x 5.6x
AMST Unlock Forecast - 30 Days FREE Trial $11M -2.6x 5.0x
APCX Unlock Forecast - 30 Days FREE Trial $16M -0.8x 11.0x
API Unlock Forecast - 30 Days FREE Trial $1569M x 2.4x
APPF Unlock Forecast - 30 Days FREE Trial $8561M 42.0x 17.2x
APPN Unlock Forecast - 30 Days FREE Trial $3023M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3351M -12.4x 17.8x
ASFT Unlock Forecast - 30 Days FREE Trial $1M x x
ATDS Unlock Forecast - 30 Days FREE Trial $0M x x
ATHR Unlock Forecast - 30 Days FREE Trial $73M x 12.4x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
AVPT Unlock Forecast - 30 Days FREE Trial $2849M 1446.0x 6.1x
AWRE Unlock Forecast - 30 Days FREE Trial $46M -8.1x 1.7x
BAND Unlock Forecast - 30 Days FREE Trial $442M -30.3x 1.1x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2550M -11.9x 3.5x
BBAI Unlock Forecast - 30 Days FREE Trial $2972M -3.9x 4.9x
BILL Unlock Forecast - 30 Days FREE Trial $5448M -533.4x 1.4x
BKYI Unlock Forecast - 30 Days FREE Trial $6M -26.8x 1.0x
BL Unlock Forecast - 30 Days FREE Trial $3476M 45.7x 10.6x
BLIN Unlock Forecast - 30 Days FREE Trial $11M -2.4x 1.1x
BLKB Unlock Forecast - 30 Days FREE Trial $3061M 88.2x 28.3x
BMR Unlock Forecast - 30 Days FREE Trial $34M x 1.9x
BNZI Unlock Forecast - 30 Days FREE Trial $7M x 1.3x
BOX Unlock Forecast - 30 Days FREE Trial $4559M 34.3x -16.8x
BRZE Unlock Forecast - 30 Days FREE Trial $3208M -36.2x 5.4x
BSQKZ Unlock Forecast - 30 Days FREE Trial $49445M 16.5x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $14392M 53.4x 12.0x
CANG Unlock Forecast - 30 Days FREE Trial $282M x 0.1x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $4828M 396.6x 2.3x
CCLD Unlock Forecast - 30 Days FREE Trial $132M 11.8x 2.3x
CCLDO Unlock Forecast - 30 Days FREE Trial $1078M 79.7x 18.6x
CCRD Unlock Forecast - 30 Days FREE Trial $184M 76.0x 3.3x
CCSI Unlock Forecast - 30 Days FREE Trial $425M 5.2x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $92294M 87.0x 17.8x
CERT Unlock Forecast - 30 Days FREE Trial $1470M 135.1x 1.4x
CFLT Unlock Forecast - 30 Days FREE Trial $7893M -15.7x 7.1x
CGNT Unlock Forecast - 30 Days FREE Trial $623M x 3.2x
CHKP Unlock Forecast - 30 Days FREE Trial $20726M x 6.7x
CLBT Unlock Forecast - 30 Days FREE Trial $4469M x 10.9x
CLOQ Unlock Forecast - 30 Days FREE Trial $24M x x
CLPS Unlock Forecast - 30 Days FREE Trial $12M x 0.7x
COUR Unlock Forecast - 30 Days FREE Trial $1403M -14.2x 2.2x
CRM Unlock Forecast - 30 Days FREE Trial $250668M 34.7x 4.2x
CRNC Unlock Forecast - 30 Days FREE Trial $548M -0.5x 3.6x
CRWD Unlock Forecast - 30 Days FREE Trial $127959M 4606.3x 31.9x
CRWV Unlock Forecast - 30 Days FREE Trial $36395M x 9.4x
CVLT Unlock Forecast - 30 Days FREE Trial $5330M 66.4x 25.3x
CWAN Unlock Forecast - 30 Days FREE Trial $5764M 14.7x 2.9x
CXM Unlock Forecast - 30 Days FREE Trial $2027M 18.0x 3.6x
CYBR Unlock Forecast - 30 Days FREE Trial $23661M x 10.0x
CYCA Unlock Forecast - 30 Days FREE Trial $7M x x
DAY Unlock Forecast - 30 Days FREE Trial $11051M 223.4x 4.1x
DBX Unlock Forecast - 30 Days FREE Trial $8189M 16.3x 0.0x
DDD Unlock Forecast - 30 Days FREE Trial $385M 24.6x 1.7x
DDOG Unlock Forecast - 30 Days FREE Trial $54796M 513.2x 15.9x
DH Unlock Forecast - 30 Days FREE Trial $267M -1.3x 0.9x
DOCU Unlock Forecast - 30 Days FREE Trial $13154M 43.5x 6.6x
DOMO Unlock Forecast - 30 Days FREE Trial $355M -3.7x 0.0x
DPLS Unlock Forecast - 30 Days FREE Trial $2M x x
DRTTF Unlock Forecast - 30 Days FREE Trial $144M 32.8x 4.6x
DSGX Unlock Forecast - 30 Days FREE Trial $7970M x 5.3x
DSNY Unlock Forecast - 30 Days FREE Trial $5M x 1.9x
DT Unlock Forecast - 30 Days FREE Trial $13415M 26.5x 4.8x
DTSS Unlock Forecast - 30 Days FREE Trial $11M -6.8x 3.5x
DUOL Unlock Forecast - 30 Days FREE Trial $9741M 25.2x 7.5x
DUOT Unlock Forecast - 30 Days FREE Trial $132M -2.8x 2.7x
EA Unlock Forecast - 30 Days FREE Trial $50776M 57.4x 8.5x
EBZT Unlock Forecast - 30 Days FREE Trial $4M x 6.6x
EGAN Unlock Forecast - 30 Days FREE Trial $271M 7.9x 3.3x
ELRA Unlock Forecast - 30 Days FREE Trial $1M x x
ESTC Unlock Forecast - 30 Days FREE Trial $7936M 11163.5x 8.9x
EVCM Unlock Forecast - 30 Days FREE Trial $1790M -59.0x 2.5x
EXFY Unlock Forecast - 30 Days FREE Trial $147M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $11M x x
FATN Unlock Forecast - 30 Days FREE Trial $39M x 1.9x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FDCT Unlock Forecast - 30 Days FREE Trial $30M x 1.8x
FNGR Unlock Forecast - 30 Days FREE Trial $80M -16.8x 5.3x
FROG Unlock Forecast - 30 Days FREE Trial $7663M -60.2x 8.9x
FRSH Unlock Forecast - 30 Days FREE Trial $3773M -49.0x 4.4x
FRSX Unlock Forecast - 30 Days FREE Trial $1545M x 260.6x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1533M -8.6x 1.6x
GDYN Unlock Forecast - 30 Days FREE Trial $804M 85.9x 1.5x
GEG Unlock Forecast - 30 Days FREE Trial $83M 5.1x 1.1x
GEGGL Unlock Forecast - 30 Days FREE Trial $789M 50.1x 10.7x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6877M x 7.7x
GMER Unlock Forecast - 30 Days FREE Trial $1M x x
GMGI Unlock Forecast - 30 Days FREE Trial $102M -247.8x 0.8x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $6199M 654.1x 6.7x
GTM Unlock Forecast - 30 Days FREE Trial $3119M 30.0x 2.0x
GWRE Unlock Forecast - 30 Days FREE Trial $18202M 197.9x 11.9x
GXAI Unlock Forecast - 30 Days FREE Trial $9M -1.3x 0.7x
HPAI Unlock Forecast - 30 Days FREE Trial $143M x 8.8x
HUBS Unlock Forecast - 30 Days FREE Trial $19835M -5033.1x 10.7x
IDAI Unlock Forecast - 30 Days FREE Trial $17M -0.7x 2.7x
IFBD Unlock Forecast - 30 Days FREE Trial $8M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7698M 3931.5x 3.1x
INLX Unlock Forecast - 30 Days FREE Trial $39M 1318.3x 3.4x
INSE Unlock Forecast - 30 Days FREE Trial $236M 4.3x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3529M -173.7x 7.3x
INTU Unlock Forecast - 30 Days FREE Trial $189290M 46.0x 9.8x
ITOX Unlock Forecast - 30 Days FREE Trial $0M x x
IVDA Unlock Forecast - 30 Days FREE Trial $5M -7.5x 0.9x
JAMF Unlock Forecast - 30 Days FREE Trial $1726M -22.8x 2.2x
KC Unlock Forecast - 30 Days FREE Trial $42795M x 4.5x
KLTR Unlock Forecast - 30 Days FREE Trial $255M 17.7x 14.4x
KVYO Unlock Forecast - 30 Days FREE Trial $8458M -19.1x 7.4x
LAW Unlock Forecast - 30 Days FREE Trial $466M -12.7x 3.6x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $51M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $10827M 50.1x 35.0x
MAPS Unlock Forecast - 30 Days FREE Trial $94M 11.9x 1.9x
MBLY Unlock Forecast - 30 Days FREE Trial $9512M -9.4x 0.8x
MDB Unlock Forecast - 30 Days FREE Trial $33326M -85.8x 11.5x
MFON Unlock Forecast - 30 Days FREE Trial $17M x x
MGIC Unlock Forecast - 30 Days FREE Trial $1119M x 5.3x
MKTW Unlock Forecast - 30 Days FREE Trial $39M 6.0x 0.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1485M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $8090M x 6.8x
MQ Unlock Forecast - 30 Days FREE Trial $2192M 51.0x 2.6x
MSFT Unlock Forecast - 30 Days FREE Trial $3591811M 34.2x 9.9x
MSGM Unlock Forecast - 30 Days FREE Trial $12M -0.7x 2.1x
MTBLY Unlock Forecast - 30 Days FREE Trial $2427M x 51.7x
MTC Unlock Forecast - 30 Days FREE Trial $69M x x
MYPS Unlock Forecast - 30 Days FREE Trial $81M -24.1x 0.3x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1407M 534.1x 1.7x
NCNO Unlock Forecast - 30 Days FREE Trial $2677M -119.0x 2.6x
NCSYF Unlock Forecast - 30 Days FREE Trial $6455M x 1.8x
NET Unlock Forecast - 30 Days FREE Trial $69834M -419.2x 51.8x
NICE Unlock Forecast - 30 Days FREE Trial $6717M x 1.9x
NOW Unlock Forecast - 30 Days FREE Trial $177334M 102.5x 15.7x
NTNX Unlock Forecast - 30 Days FREE Trial $14M 0.2x -21.5x
NTWK Unlock Forecast - 30 Days FREE Trial $36M 32.6x 1.0x
NUGN Unlock Forecast - 30 Days FREE Trial $2M x 0.1x
NXNT Unlock Forecast - 30 Days FREE Trial $8M x x
OKTA Unlock Forecast - 30 Days FREE Trial $15408M 79.0x 2.2x
ONTF Unlock Forecast - 30 Days FREE Trial $254M -6.7x 1.8x
OS Unlock Forecast - 30 Days FREE Trial $3M x 0.0x
PATH Unlock Forecast - 30 Days FREE Trial $10123M 501.9x 6.1x
PAYC Unlock Forecast - 30 Days FREE Trial $9164M 20.2x 5.4x
PCOR Unlock Forecast - 30 Days FREE Trial $11671M -134.0x 9.5x
PCTY Unlock Forecast - 30 Days FREE Trial $7967M 35.3x 7.2x
PD Unlock Forecast - 30 Days FREE Trial $1156M 7.5x 3.6x
PDFS Unlock Forecast - 30 Days FREE Trial $1175M 1281.6x 4.5x
PDYN Unlock Forecast - 30 Days FREE Trial $239M -3.0x 4.6x
PDYNW Unlock Forecast - 30 Days FREE Trial $5M 0.0x 0.1x
PLTR Unlock Forecast - 30 Days FREE Trial $433191M 395.5x 65.7x
PNXP Unlock Forecast - 30 Days FREE Trial $0M x 1.6x
PRCH Unlock Forecast - 30 Days FREE Trial $1101M 36.0x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1868M 38.5x 3.9x
PTC Unlock Forecast - 30 Days FREE Trial $20742M 28.3x 5.4x
QLYS Unlock Forecast - 30 Days FREE Trial $5245M 27.7x 9.9x
QTWO Unlock Forecast - 30 Days FREE Trial $4596M 144.8x 7.4x
RBLX Unlock Forecast - 30 Days FREE Trial $67576M -35.7x 165.8x
RBRK Unlock Forecast - 30 Days FREE Trial $16675M x 0.0x
RCAT Unlock Forecast - 30 Days FREE Trial $948M -91.1x 3.7x
RDVT Unlock Forecast - 30 Days FREE Trial $747M 66.7x 7.3x
RPD Unlock Forecast - 30 Days FREE Trial $1043M 55.6x 8.2x
RPMT Unlock Forecast - 30 Days FREE Trial $52M x x
RTCJF Unlock Forecast - 30 Days FREE Trial $23M x 0.9x
S Unlock Forecast - 30 Days FREE Trial $4770M -25.6x 3.1x
SAIL Unlock Forecast - 30 Days FREE Trial $11266M -73.2x 1.7x
SBET Unlock Forecast - 30 Days FREE Trial $2060M x 0.7x
SEMR Unlock Forecast - 30 Days FREE Trial $1754M 169.4x 6.1x
SHOP Unlock Forecast - 30 Days FREE Trial $211019M 432.4x 16.9x
SKIL Unlock Forecast - 30 Days FREE Trial $87M -1.4x 2.0x
SKKY Unlock Forecast - 30 Days FREE Trial $23M x 24.7x
SMSI Unlock Forecast - 30 Days FREE Trial $13M -0.2x 0.7x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNOW Unlock Forecast - 30 Days FREE Trial $76845M -54.7x 36.0x
SNPS Unlock Forecast - 30 Days FREE Trial $86565M 43.3x 3.1x
SPNS Unlock Forecast - 30 Days FREE Trial $2421M x 5.1x
SPSC Unlock Forecast - 30 Days FREE Trial $3158M 37.1x 3.3x
SPT Unlock Forecast - 30 Days FREE Trial $625M -27.5x 3.2x
SSNC Unlock Forecast - 30 Days FREE Trial $21506M 25.2x 3.1x
SSTI Unlock Forecast - 30 Days FREE Trial $79M -38.0x 1.1x
SVCO Unlock Forecast - 30 Days FREE Trial $139M x 1.8x
TAOP Unlock Forecast - 30 Days FREE Trial $15M x 1.0x
TDC Unlock Forecast - 30 Days FREE Trial $2881M 24.4x 13.2x
TEAM Unlock Forecast - 30 Days FREE Trial $41902M -233.9x 30.4x
TENB Unlock Forecast - 30 Days FREE Trial $3182M -81.5x 9.2x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $9614M x 6.5x
TTWO Unlock Forecast - 30 Days FREE Trial $45783M -9.7x 13.3x
TWLO Unlock Forecast - 30 Days FREE Trial $20398M 303.5x 2.6x
TYL Unlock Forecast - 30 Days FREE Trial $22597M 71.7x 6.3x
U Unlock Forecast - 30 Days FREE Trial $19584M -13.5x 6.1x
UMEWF Unlock Forecast - 30 Days FREE Trial $32M x 1.6x
VBIX Unlock Forecast - 30 Days FREE Trial $17M x 3.0x
VEEV Unlock Forecast - 30 Days FREE Trial $39771M 46.2x 5.7x
VPRB Unlock Forecast - 30 Days FREE Trial $4M x x
VRNS Unlock Forecast - 30 Days FREE Trial $3561M -27.4x 5.9x
VWAV Unlock Forecast - 30 Days FREE Trial $24M x x
WBSR Unlock Forecast - 30 Days FREE Trial $12M x x
WEAV Unlock Forecast - 30 Days FREE Trial $502M -36.7x 6.4x
WFCF Unlock Forecast - 30 Days FREE Trial $65M 32.5x 6.3x
WHEN Unlock Forecast - 30 Days FREE Trial $83M x 59.7x
WIMI Unlock Forecast - 30 Days FREE Trial $72M x 0.1x
WK Unlock Forecast - 30 Days FREE Trial $5193M -70.2x 0.0x
XPER Unlock Forecast - 30 Days FREE Trial $279M 40.0x 0.7x
XYZ Unlock Forecast - 30 Days FREE Trial $38209M 12.2x 1.7x
YOU Unlock Forecast - 30 Days FREE Trial $2940M 16.2x 10.1x
ZDGE Unlock Forecast - 30 Days FREE Trial $32M -4.8x 1.2x
ZETA Unlock Forecast - 30 Days FREE Trial $4142M -26.5x 6.0x
ZSPC Unlock Forecast - 30 Days FREE Trial $11M x -3.2x

Frequently Asked Questions - Xperi Inc. Stock Forecast

How accurate are Xperi Inc. stock predictions?

Our AI model shows a 47% Spearman correlation coefficient for XPER predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Xperi Inc. stock price forecasts?

Our analysis considers Xperi Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Xperi Inc. a good investment in 2025?

Based on our AI analysis, Xperi Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Xperi Inc. forecasts updated?

Xperi Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Xperi Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Xperi Inc. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...